Previous Article | Next Article 
Clinical and Diagnostic Laboratory Immunology, May 2000, p. 417-421, Vol. 7, No. 3
1071-412X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Treponema pallidum Surface
Immunofluorescence Assay for Serologic Diagnosis of Syphilis
Antonella
Marangoni,1
Vittorio
Sambri,1
Elisa
Storni,1
Antonietta
D'Antuono,2
Massimo
Negosanti,2 and
Roberto
Cevenini1,*
Sezione di
Microbiologia1 and Sezione di Clinica
Dermatologica,2 DMCSS, University of
Bologna, St. Orsola Hospital, 40138 Bologna, Italy
Received 30 September 1999/Returned for modification 29 December
1999/Accepted 18 February 2000
 |
ABSTRACT |
A surface immunofluorescence assay (SIFA) using live spirochetes
was analyzed and compared with Western blot (WB), fluorescent treponemal antibody absorption (FTA-ABS), microhemagglutination (MHA-TP), and Treponema pallidum immobilization (TPI)
assays for detecting serum antibodies to T. pallidum in
patients with syphilis, in disease controls, and in healthy subjects.
SIFA and WB were 99% sensitive (99 of 100 positive specimens) and
specific (140 of 140 negative specimens); FTA-ABS showed a sensitivity
and a specificity of 90 and 89% (90 of 100 positive and 125 of 140 negative specimens), respectively. MHA-TP showed a sensitivity of 84%
(84 of 100 positive specimens) and a specificity of 98.5% (138 of 140 negative specimens). Finally, TPI had a sensitivity of 52% (52 of 100 positive specimens) and a specificity of 100% (140 of 140 negative
specimens). The T. pallidum SIFA was therefore highly
specific, showing no equivocal reactivities with control sera, and
sensitive. The results suggest the possible use of SIFA as a
confirmatory test in the serologic diagnosis of syphilis.
 |
INTRODUCTION |
The diagnosis of syphilis depends on
clinical findings, examination of lesions for treponemes, and/or
serologic tests. Serologic tests are divided into nontreponemal and
treponemal tests. Nontreponemal tests are useful for screening, while
treponemal tests are used as confirmatory tests. In practice, two or
three assays are performed in series for the serologic diagnosis of
syphilis (22, 28). First, sera are screened in a
microflocculation assay, such as the Venereal Disease Research
Laboratory test (VDRL), using nontreponemal antigens (25).
Reactive sera are then tested for antibodies specific for
Treponema pallidum antigens by using the fluorescent treponemal antibody absorption assay (FTA-ABS) or the
microhemagglutination assay (MHA-TP) (12, 22, 28). Since the
mid-1980s, the Western blot assay (WB), set up with boiled sodium
dodecyl sulfate extracts of T. pallidum, has been introduced
as an alternative to the other confirmatory methods (5, 13,
15). In addition, among the treponemal tests, several enzyme
immunoassays have been described and evaluated, showing sensitivities
and specificities similar to those of FTA-ABS and MHA-TP (9, 11,
23, 37).
Currently, the T. pallidum immobilization test (TPI), the
first treponemal antibody test developed (by Nelson and Mayer in 1949 [26]), is limited to mostly research purposes, since
it is complex and technically difficult. The test is based on the ability of the patient's antibody to bind to the surface of T. pallidum (2) and to immobilize living spirochetes in
the presence of complement, as observed by dark-field microscopy. TPI
is accepted as a specific test for syphilis, though it is less
sensitive than the newer treponemal tests (30).
Previous observations from our laboratory showed the high specificity
of surface immunofluorescence assay (SIFA) performed with live
Borrelia burgdorferi spirochetes for the detection of serum-specific antibodies against surface antigens of the Lyme disease
agent (7). In this study, we investigated the sensitivity and specificity of SIFA both for the detection of specific antibodies against T. pallidum and for the serologic diagnosis of syphilis.
 |
MATERIALS AND METHODS |
Study groups.
One hundred patients (74 males and 26 females)
between 21 and 68 years of age (mean age, 37.2 years) suffering from
syphilis were studied. The diagnosis, based on clinical and laboratory data, was early syphilis for 46 patients (i.e., primary syphilis for 26 patients and secondary syphilis for 20 patients), early latent syphilis
for 50 patients, and late syphilis for 4 patients. Sixteen patients
with primary syphilis and three with secondary syphilis were human
immunodeficiency virus (HIV)-positive.
The stage classification of syphilis was made by following the
guidelines proposed by Norris and Larsen (28). One serum sample, obtained at the time of the clinical diagnosis, was used for
serologic study. Fifty sera from healthy blood donors, 20 sera from
patients suffering from Lyme disease (16) previously serologically characterized in our laboratory, and 20 sera from patients suffering from leptospirosis (obtained from M. S. Nuncio, Instituto Nacional de Saude, Aguas De Moura, Portugal) were studied as
controls and disease controls, respectively. In addition, 50 serum
samples positive by VDRL and negative by MHA-TP, WB, and TPI were also
included in the study. These sera were defined as biological
false-positive (BFP) reactors (3, 4, 14, 18, 31), since they
were from subjects without clinical signs or symptoms of syphilis,
i.e., 10 healthy, pregnant women, 15 patients suffering from
dermatological diseases (such as systemic lupus erythematosus or
chicken pox), 15 patients with HIV infection, 5 patients with viral
hepatitis showing autoimmune reactions, and 5 patients with diabetes mellitus.
Source of T. pallidum.
Treponema pallidum subsp.
pallidum (Nichols strain), originally purchased from the
Statens Serum Institut, Copenhagen, Denmark, was maintained in adult
male New Zealand White rabbits by testicular passage (24).
Infected rabbits were individually housed, maintained at 16 to 18°C,
and given antibiotic-free food and water ad libitum. Each treponemal
suspension was prepared from infected rabbit testicles from 10 to 14 days after inoculation (24).
VDRL.
A commercial kit was used by following the
manufacturer's instructions (Behring AG, Marburgan der Lahn, Germany).
The results were read under light microscopy at a ×100 magnification.
FTA-ABS.
Serum samples were tested by a fluorescent T. pallidum-specific assay (Trepo Spot IF, BioMerieux SA, Marcy
l'Etoile, France) by using microscope slides coated with T. pallidum (Nichols strain) whole antigen. Sera were preliminarily
screened by following the plus (+) score system proposed by the
manufacturer. Afterwards, all the samples scored as 1+ were retested by
using serial twofold dilutions starting from 1/5 up to 1/40. Since the
1+ sera were positive at a dilution of <1:20, they were considered
negative according to the previously reported data of Larsen and
coworkers (21). The specimens scoring above the 1+ level
were retested by diluting samples from 1:10 up to 1:640. A reaction was
considered positive when at least 80% of the spirochetes gave a
brilliant green fluorescence at a serum dilution of
1:20.
MHA-TP.
Quantitative MHA-TP testing (MHA-TP, Fujirebio,
Tokyo, Japan) was performed in accordance with the manufacturer's
instructions, which had an established cutoff of a 1:80 dilution.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and
WB.
Treponemal suspensions obtained from infected rabbit testicles
were diluted in sample buffer to 109 organisms per ml, as
determined by dark-field microscopy examination at a magnification of
×400. The separation of T. pallidum polypeptides was
performed with a Laemmli buffer system (19) by using a 12% acrylamide gel as described elsewhere (6). The WB procedure of Towbin et al. (35) was performed as described elsewhere
(6). After electrophoretic transfer, the blots were
incubated for 12 h at room temperature with sera diluted 1:100 in
phosphate-buffered saline containing 0.05% (vol/vol) Tween 20. Antigen-antibody complexes were detected with peroxidase-labeled rabbit
antiserum to total human immunoglobulin (Ig) (Dako, Copenhagen,
Denmark) diluted 1:500 in phosphate-buffered saline and with
4-chloro-1-naphthol (Bio-Rad, Hercules, Calif.) as the enzyme substrate.
A test was considered positive when at least three of four
T. pallidum specific bands with apparent molecular masses of 15.5,
17, 44.5, and 47 kDa were present (
5,
27). A test was
considered
negative when no band or fewer than three of the
above-mentioned
T. pallidum antigens were recognized
(
5). The apparent molecular
weight of each band was
determined by comparative plotting of
the positions of Rainbow
low-molecular-weight standards (Amersham-Pharmacia,
Amersham, United
Kingdom). Positive and negative control sera
were run with test
specimens. The positive control was prepared
by pooling 20 different
sera from patients suffering from syphilis
at different stages: each
individual serum sample was positive
by both WB and MHA-TP (titer
range, 640 to 5,120) as well as the
serum pool that was positive by WB
and MHA-TP (titer = 1,280).
As a negative control, a serum pool of
20 samples from healthy
blood donors was used. This serum pool was
negative by both MHA-TP
(titer < 80) and
WB.
TPI.
TPI was performed by following the guidelines of the
Centers for Disease Control and Prevention (36). Briefly,
treponemes were extracted from rabbit testis in basal medium
(36) under anaerobic conditions and were incubated with
serum samples (with or without added complement) in anaerobic jars at
35°C for 16 to 18 h. All sera were tested in duplicate to ensure
the validity of the procedure. A test was considered negative if the
difference between the average number of motile treponemes, determined
by dark-field microscopy (magnification, ×400), of the two "test" tubes and the "control" tube (i.e., the tube without complement added) was 20% or less. A test was considered positive if the difference between the average count of motile spirochetes in the two
test tubes and the control tube was 50% or greater. In order to be
validated, in the control tube at least 70% active motile treponemes
had to be read. Specimens were always tested in a blind fashion.
SIFA.
Serum samples were tested by SIFA as previously
reported (7, 32), with slight modifications. Sera were
inactivated at 56°C for 1 h, diluted 1:20 in a suspension of
100% motile treponemes extracted from infected rabbit testicles
(108 bacteria/ml) in the medium described by Stamm and
Bassford (34), and incubated under an atmosphere of 95%
N2-5% CO2 at 37°C for 1 h. After the
incubation period, the viability of treponemes was checked again by
dark-field microscopy. In order to validate the test, at least 99% of
treponemes had to be motile. The suspension was then pelleted by
centrifugation at 10,000 × g for 20 min, and washed
three times in phosphate-buffered saline. The treponemes were diluted
to a final concentration of 107 bacteria/ml, spotted (10 µl) onto microscope slides, air dried, and fixed with cold acetone
for 10 min. Igs bound to T. pallidum surface-exposed
antigens were detected by using fluorescein-conjugated rabbit
anti-human total Ig (Dako), diluted 1:40 in phosphate-buffered saline.
The results were read under UV light microscopy at a magnification of
×400.
 |
RESULTS |
Antibodies against T. pallidum surface-exposed antigens
were easily detectable in sera from syphilitic patients by SIFA.
Positive sera induced a bright fluorescence of treponemes that appeared slightly more slender than bacteria stained by FTA-ABS (Fig.
1).

View larger version (141K):
[in this window]
[in a new window]
|
FIG. 1.
Photomicrograph of T. pallidum stained by
SIFA. Living spirochetes were incubated with T. pallidum-positive (A) and -negative (B) human serum samples.
Magnification, ×320. (C and D) T. pallidum stained by SIFA
and by FTA-ABS, respectively, at a higher magnification (×800). The
spirochetes stained by SIFA appear slightly more slender than those
stained by FTA-ABS.
|
|
The results obtained in the various stages of syphilitic infection by
SIFA are reported in Table 1 and compared
with the results obtained by the other serologic methods. SIFA, WB
(Fig. 2), and VDRL were the most
sensitive methods in the early stage of syphilis, since 45 out of 46 serum samples were positive by these methods; the serum sample negative
by these tests was from a patient showing a chancre lesion from which
treponemes were identified by dark-field microscopy. It is interesting
that 6 out of 16 HIV-infected patients with primary syphilis and 1 out of 3 HIV-infected patients with secondary syphilis were positive by
SIFA, WB, and VDRL but negative by FTA-ABS and MHA-TP. All (n = 50) serum samples from patients with early latent
syphilis were positive by SIFA, WB, FTA-ABS, and VDRL, whereas 92% (46 of 50) and 72% (36 of 50) of the sera were positive by MHA-TP and TPI,
respectively. Late-syphilis sera were positive by all the tests. Tables
2 to
5
report the comparison of results obtained by SIFA with results obtained
by the other treponemal tests (WB, FTA-ABS, MHA-TP, and TPI) in testing
specimens from syphilis patients, healthy donors, Lyme disease
patients, and leptospirosis patients and in testing BFP samples. The
sensitivity and specificity of SIFA and of the other methods were as
follows. SIFA and WB were 99% sensitive (99 of 100 positive specimens)
and specific (140 of 140 negative specimens, including 50 BFP reactors,
50 healthy blood donors' samples, 20 samples of patients with Lyme
disease, and 20 samples of patients suffering from leptospirosis).
FTA-ABS showed a sensitivity and a specificity of 90 and 89%,
respectively (90 of 100 positive and 125 of 140 negative specimens).
MHA-TP showed a sensitivity of 84% (84 of 100 positive specimens) and a specificity of 98.5% (138 of 140 negative specimens). Finally, TPI
showed a sensitivity of 52% (52 of 100 positive specimens) and a
specificity of 100% (140 of 140 negative specimens).
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Results obtained by T. pallidum SIFA, WB,
FTA-ABS, MHA-TP, TPI, and VDRL in serum samples from patients
with syphilis
|
|

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 2.
WB analysis of human sera with T. pallidum
whole-cell preparation. (A) Sample from a positive serum pool (lane 1)
and two serum samples from patients with early latent syphilis (lanes 2 and 3). These samples clearly recognized four T. pallidum
bands of 15.5, 17.0, 44.5, and 47.0 kDa. These bands are considered
diagnostic for T. pallidum infection when at least three of
them are detected (5, 27). (B) Lanes 1 and 2 were probed
with two sera defined as BFP reactors since they were positive by VDRL
but negative by MHA-TP and TPI. Also, WB was negative since the sera
recognized only two of the four above-mentioned T. pallidum
bands (the 47.0- and 44.5-kDa bands). The apparent molecular masses of
individual T. pallidum proteins are shown in the middle.
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Comparison of FTA-ABS and SIFA reactivities in sera from
patients with syphilis, in sera defined as BFP reactors, in sera from
healthy blood donors, and in sera from patients with Lyme disease
or leptospirosis
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 3.
Comparison of MHA-TP and SIFA reactivities in sera from
patients with syphilis, in sera defined as BFP reactors, in sera from
healthy blood donors, and in sera from patients with Lyme disease
or leptospirosis
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 4.
Comparison of WB and SIFA reactivities in sera from
patients with syphilis, in sera defined as BFP reactors, in sera from
healthy blood donors, and in sera from patients with Lyme disease
or leptospirosis
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 5.
Comparison of TPI and SIFA reactivities in sera from
patients with syphilis, in sera defined as BFP reactors, in sera from
healthy blood donors, and in sera from patients with Lyme disease
or leptospirosis
|
|
 |
DISCUSSION |
The reliability of immunological reactions between antibodies and
surface-exposed antigens of the spirochete B. burgdorferi that are caused by using living organisms and SIFA has been previously shown by members of our group (7) and subsequently confirmed by Cox et al. (8). In this study, we compared SIFA for the detection of antibodies against T. pallidum with other
treponemal serologic tests. The sensitivity of SIFA and WB was 99%; in
contrast, FTA-ABS and MHA-TP were less sensitive, with values of 90 and 84%, respectively. In fact, FTA-ABS and MHA-TP failed to recognize antitreponemal antibodies in 7 out of 19 specimens from HIV-infected patients suffering from primary or secondary syphilis, in contrast with
SIFA, WB, and VDRL. The reliability of syphilis serology in patients
with HIV infection has been questioned (10, 17, 33), and the
need for a good test for this group of patients is well known, because
of the false-negative results that can be obtained by using the classic
treponemal serologic methods. TPI was the least sensitive method,
showing a sensitivity of 52%, in agreement with previous reported data
(30). The specificity of SIFA was analyzed by testing sera
from several control groups. None of these sera was found to be
reactive by SIFA (specificity, 100%). Similar results were obtained by
WB and TPI. MHA-TP showed high specificity (98.5%), whereas FTA-ABS
was less specific (89%), since several BFP samples and sera from
patients with Lyme disease gave false-positive reactions. These data
are in agreement with those reported by other authors (3, 4, 14,
18, 20).
When the SIFA-positive sera were tested by WB, all of them clearly
recognized at least three out of the four T. pallidum bands with apparent molecular masses of 15.5, 17.0, 44.5, and 47.0 kDa, which
are considered diagnostic for T. pallidum infection (5, 27). In addition, the sera recognized several other variable bands. It is known that none of the four T. pallidum bands
considered diagnostic for T. pallidum infection is surface
exposed (1, 27). Therefore, the antibodies reactive in SIFA
were not those involved in the recognition of these T. pallidum antigens by WB. On the other hand, it is unlikely that
the rare outer membrane proteins of T. pallidum described by
Blanco et al. (1) and by Radolf et al. (29) could
be reliably identified by WB, at least under our experimental
conditions, due to their scanty representation on the bacterial surface
(1, 29). In fact, it has been shown that T. pallidum surface proteins can be reliably detected by WB only by
using enriched outer membrane protein preparations (1, 29).
Notwithstanding this, the specificity of SIFA was demonstrated in our
study by comparing the T. pallidum SIFA results with
T. pallidum WB results obtained in detecting other
diagnostic, albeit not surface-exposed, T. pallidum proteins.
In conclusion, the results obtained in the present study demonstrate
that antibodies reactive with the surface-exposed antigens of live
T. pallidum organisms are highly specific for syphilitic infection, showing no equivocal reactivities with the various control
sera used. This observation confirms previous data regarding the
specificity of antibodies reactive with the surface antigens of the
spirochete B. burgdorferi in patients suffering from Lyme disease (7). In contrast with B. burgdorferi
SIFA, which proved sensitive only for late Lyme disease (7),
the T. pallidum SIFA was highly sensitive for both early and
late syphilis. These results therefore suggest the possibility of using
the T. pallidum SIFA as a confirmatory test in the serologic
diagnosis of syphilis.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Sezione di
Microbiologia, DMCSS, University of Bologna, St. Orsola Hospital, via
Massarenti 9, 40138 Bologna, Italy. Phone: 39 051 4290913. Fax: 39 051 341632. E-mail: cevenini{at}almadns.unibo.it.
 |
REFERENCES |
| 1.
|
Blanco, D. R.,
J. N. Miller, and M. A. Lovett.
1997.
Surface antigens of the syphilis spirochete and their potential as virulence determinants.
Emerg. Infect. Dis.
3:11-20[Medline].
|
| 2.
|
Blanco, D. R.,
E. M. Walker,
D. A. Haake,
C. I. Champion,
J. N. Miller, and M. A. Lovett.
1990.
Complement activation limits the rate of in vitro treponemicidal activity and correlates with antibody-mediated aggregation of Treponema pallidum rare outer membrane protein.
J. Immunol.
144:1914-1921[Abstract].
|
| 3.
|
Brauner, A.,
B. Carlsson,
G. Sundkvist, and C. G. Ostenson.
1994.
False-positive treponemal serology in patients with diabetes mellitus.
J. Diabetes Complicat.
8:57-62[CrossRef][Medline].
|
| 4.
|
Buchanan, C. S., and J. R. Haserick.
1970.
FTA-ABS test in pregnancy: a probable false-positive reaction.
Arch. Dermatol.
102:333-335[Abstract/Free Full Text].
|
| 5.
|
Byrne, R. E.,
S. Laska,
M. Bell,
D. Larson,
J. Phillips, and J. Todd.
1992.
Evaluation of a Treponema pallidum Western immunoblot assay as a confirmatory test for syphilis.
J. Clin. Microbiol.
30:115-122[Abstract/Free Full Text].
|
| 6.
|
Cevenini, R.,
F. Rumpianesi,
V. Sambri, and M. La Placa.
1986.
Antigenic specificity of serological response in Chlamydia trachomatis urethritis detected by immunoblotting.
J. Clin. Pathol.
39:335-337[Abstract/Free Full Text].
|
| 7.
|
Cevenini, R.,
V. Sambri,
F. Massaria,
R. Franchini,
A. D'Antuono,
G. Borda, and M. Negosanti.
1992.
Surface immunofluorescence assay for diagnosis of Lyme disease.
J. Clin. Microbiol.
30:2456-2461[Abstract/Free Full Text].
|
| 8.
|
Cox, D. L.,
D. R. Akins,
K. W. Bourell,
P. Lahdenne,
M. V. Norgard, and J. D. Radolf.
1996.
Limited surface exposure of Borrelia burgdorferi outer surface lipoproteins.
Proc. Natl. Acad. Sci. USA
93:7973-7978[Abstract/Free Full Text].
|
| 9.
|
Ebel, A.,
L. Bachelart, and J.-M. Alonso.
1998.
Evaluation of a new competitive immunoassay (BioElisa Syphilis) for screening for Treponema pallidum antibodies at various stages of syphilis.
J. Clin. Microbiol.
36:358-361[Abstract/Free Full Text].
|
| 10.
|
Erbelding, E. J.,
D. Vlahov,
K. E. Nelson,
A. M. Rompalo,
S. Cohn,
P. Sanchez,
T. C. Quinn,
W. Brathwaite, and D. L. Thomas.
1997.
Syphilis serology in human immunodeficiency virus infection: evidence for false-negative fluorescent treponemal testing.
J. Infect. Dis.
176:1397-1400[Medline].
|
| 11.
|
Farshy, C. E.,
E. F. Hunter,
L. O. Helsel, and S. A. Larsen.
1985.
Four-step enzyme-linked immunosorbent assay for detection of Treponema pallidum antibody.
J. Clin. Microbiol.
21:387-389[Abstract/Free Full Text].
|
| 12.
|
Farshy, C. E.,
E. F. Hunter,
V. Pope,
S. A. Larsen, and J. C. Feeley.
1986.
Four serologic tests for syphilis: results with comparison of selected groups of sera.
Sex. Transm. Dis.
13:228-231[Medline].
|
| 13.
|
George, R. W.,
V. Pope, and S. A. Larsen.
1991.
Use of the Western blot for the diagnosis of syphilis.
Clin. Immunol. Newsl.
8:124-133.
|
| 14.
|
Gibowski, M., and E. Neumann.
1980.
Non-specific positive test results to syphilis in dermatological diseases.
Br. J. Vener. Dis.
56:17-19[Medline].
|
| 15.
|
Hensel, U.,
H.-J. Wellensiek, and S. Bhakdi.
1985.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis immunoblotting as a serological tool in the diagnosis of syphilitic infections.
J. Clin. Microbiol.
21:82-87[Abstract/Free Full Text].
|
| 16.
|
Hunter, E. F.,
H. Russell,
C. E. Farshy,
J. S. Sampson, and S. A. Larsen.
1986.
Evaluation of sera from patients with Lyme disease in the fluorescent treponemal antibody-absorption test for syphilis.
Sex. Transm. Dis.
13:233-236.
|
| 17.
|
Johnson, P. D. R.,
S. R. Graves,
L. Stewart,
R. Warren,
B. Dwyer, and C. R. Lucas.
1991.
Specific syphilis serological tests may become negative in HIV infection.
AIDS
5:419-423[Medline].
|
| 18.
|
Kraus, S. J.,
J. R. Haserick, and M. Lantz.
1970.
Fluorescent treponemal antibody-absorption test reactions in lupus erythematosus. Atypical beading pattern and probable false-positive reactions.
N. Engl. J. Med.
333:1247-1251.
|
| 19.
|
Laemmli, U. K.
1970.
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature (London)
227:680-685[CrossRef][Medline].
|
| 20.
|
Larsen, S. A.,
E. A. Hambie,
D. E. Pettit,
M. W. Perryman, and S. J. Kraus.
1981.
Specificity, sensitivity, and reproducibility among the fluorescent treponemal antibody-absorption test, the microhemagglutination assay for Treponema pallidum antibodies, and the hemagglutination treponemal test for syphilis.
J. Clin. Microbiol.
14:441-445[Abstract/Free Full Text].
|
| 21.
|
Larsen, S. A.,
C. E. Farshy,
B. J. Pender,
M. R. Adams,
D. E. Pettit, and E. A. Hambie.
1986.
Staining intensities in the fluorescent treponemal antibody-absorption (FTA-Abs) test: association with the diagnosis of syphilis.
Sex. Transm. Dis.
13:221-227[Medline].
|
| 22.
|
Larsen, S. A.,
B. M. Steiner, and A. H. Rudolph.
1995.
Laboratory diagnosis and interpretation of tests for syphilis.
Clin. Microbiol. Rev.
8:1-21[Abstract].
|
| 23.
|
Lefevre, J.-C.,
M.-A. Bertrand, and R. Bauriaud.
1990.
Evaluation of the Captia enzyme immunoassays for detection of immunoglobulins G and M to Treponema pallidum in syphilis.
J. Clin. Microbiol.
28:1704-1707[Abstract/Free Full Text].
|
| 24.
|
Miller, J. N.,
S. J. Whang, and F. P. Fazzan.
1963.
Studies on immunity in experimental syphilis. Treponema pallidum immobilization (TPI) antibody and the immune response.
Br. J. Vener. Dis.
39:199-203[Medline].
|
| 25.
|
Musher, D.
1990.
Biology of T. pallidum, p. 205-211.
In
K. K. Holmes, P. Mardh, P. F. Spardling, et al. (ed.), Sexually transmitted diseases, 2nd ed. McGraw-Hill, New York, N.Y.
|
| 26.
|
Nelson, R. A., Jr., and M. M. Mayer.
1949.
Immobilization of Treponema pallidum in vitro by antibody produced in syphilitic infection.
J. Exp. Med.
89:369-393[Abstract].
|
| 27.
|
Norris, S. J., and the Treponema pallidum Polypeptide Research Group.
1993.
Polypeptides of Treponema pallidum: progress toward understanding their structural, functional, and immunologic roles.
Microbiol. Rev.
57:750-779[Abstract/Free Full Text].
|
| 28.
|
Norris, S. J., and S. A. Larsen.
1995.
Treponema and other host-associated spirochetes, p. 636-651.
In
P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C.
|
| 29.
|
Radolf, J. D.,
E. J. Robinson,
K. W. Bourell,
D. R. Akins,
S. F. Porcella,
L. M. Weigel,
J. D. Jones, and M. V. Norgard.
1995.
Characterization of outer membranes isolated from Treponema pallidum, the syphilis spirochete.
Infect. Immun.
63:4244-4252[Abstract].
|
| 30.
|
Rein, M. F.,
G. W. Banks,
L. C. Logan,
S. A. Larsen,
J. C. Feeley,
D. S. Kellog, and P. J. Wiesner.
1980.
Failure of the Treponema pallidum immobilization test to provide additional diagnostic information about contemporary problem sera.
Sex. Transm. Dis.
7:101-105[Medline].
|
| 31.
|
Rompalo, A. M.,
R. O. Cannon,
T. C. Quinn, and E. W. Hook.
1992.
Association of biological false-positive reactions for syphilis with human immunodeficiency virus infection.
J. Infect. Dis.
165:1124-1126[Medline].
|
| 32.
|
Sambri, V.,
A. Marangoni,
F. Massaria,
A. Farencena,
M. LaPlaca, Jr., and R. Cevenini.
1995.
Functional activities of antibodies directed against surface lipoproteins of Borrelia hermsii.
Microbiol. Immunol.
39:623-627[Medline].
|
| 33.
|
Sjovall, P.
1991.
HIV infection and loss of treponemal test reactivity.
Acta Dermato-Venereol.
71:458[Medline].
|
| 34.
|
Stamm, L. V., and P. J. Bassford, Jr.
1985.
Cellular and extracellular protein antigens of Treponema pallidum synthesized during in vitro incubation of freshly extracted organisms.
Infect. Immun.
47:799-807[Abstract/Free Full Text].
|
| 35.
|
Towbin, H.,
T. Staehelin, and J. Gordon.
1979.
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
Proc. Natl. Acad. Sci. USA
76:4350-4354[Abstract/Free Full Text].
|
| 36.
|
U.S. Department of Health, Education, and Welfare.
1964.
Serologic tests for syphilis, p. 69-85.
Communicable Disease Center, Venereal Disease Branch, Public Health Service, Atlanta, Ga.
|
| 37.
|
Young, H.,
A. Moyes, and J. D. Ross.
1995.
Markers of past syphilis in HIV infection comparing Captia Syphilis G anti-treponemal IgG enzyme immunoassay with other treponemal antigen tests.
Int. J. STD AIDS
6:101-104[Medline].
|
Clinical and Diagnostic Laboratory Immunology, May 2000, p. 417-421, Vol. 7, No. 3
1071-412X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Giacani, L., Sambri, V., Marangoni, A., Cavrini, F., Storni, E., Donati, M., Corona, S., Lanzarini, P., Cevenini, R.
(2005). Immunological Evaluation and Cellular Location Analysis of the TprI Antigen of Treponema pallidum subsp. pallidum. Infect. Immun.
73: 3817-3822
[Abstract]
[Full Text]
-
Sambri, V., Marangoni, A., Giacani, L., Gennaro, R., Murgia, R., Cevenini, R., Cinco, M.
(2002). Comparative in vitro activity of five cathelicidin-derived synthetic peptides against Leptospira, Borrelia and Treponema pallidum. J Antimicrob Chemother
50: 895-902
[Abstract]
[Full Text]
-
Sambri, V., Marangoni, A., Eyer, C., Reichhuber, C., Soutschek, E., Negosanti, M., D'Antuono, A., Cevenini, R.
(2001). Western Immunoblotting with Five Treponema pallidum Recombinant Antigens for Serologic Diagnosis of Syphilis. CVI
8: 534-539
[Abstract]
[Full Text]